New hires and promotions in the med-tech industry, including: Immunovia, Prosomnus.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: BMS, Cstone, Dynavax, Eisai, Incyclix, Jaguar, Laevoroc, Ocugen, Transcode, Verrica, Ymmunobio.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alessa, Allogene, Altea, Biostax, Biontech, Celanese, Eisai, ICER, Immune, Immunogen, Vertex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aim, Aldeyra, Aptinyx, Arrowhead, Aslan, Cybin, Eloxx, Innovent, Junshi, JW, Merck & Co., Nascent, Qsam.

Biopharmas raising money in public or private financings, including: 2seventy, Cipher, HC, Thymmune, Travere.

New hires and promotions in the biopharma industry, including: Bioarctic, Centessa, Kineta, Lipella, Marengo, Poseida, Revance, Strand, Tango.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: ABVC, Alterity, Astellas, Astrazeneca, Beigene, Biosyngen, Daiichi Sankyo, Fapon, GC, GSK, Merck, Mezzion, Moderna, Pfizer, Ridgeback, Roche, RVAC Medicines, Sinovac, Specialised, Vir.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Adimmune, Biocytogen, Biosenic, Celltrion Healthcare, Chipscreen, Clover, Cue, Essex Bio-Technology, Fatiabgen, Gilead Sciences, Kinnate, Kinnjiu, Liscure, Myeloid, Ono, Ordaōs, Shanghai Henlius, Shenzhen Pregene.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alteogen, Amniotics, Ascletis, Aslan, Astellas, Atea, Bridge, Effector, Horizon, Innocare, Junshi, Keymed, Kinarus, Merck, Neurophth, Oscotec, Shionogi, Shionogi, Takeda, Telix, Westvac.

Biopharmas in Asia-Pacific raising money in public or private financings: Aslan.